RecoverLINK Technology Pilot for HF Patients
| Status: | Completed |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 9/2/2018 |
| Start Date: | February 2016 |
| End Date: | June 2018 |
Pilot to Assess Feasibility of Using RecoverLINK Technology to Supplement Outpatient Care for Heart Failure Patients
The primary objective is to examine feasibility of incorporating RecoverLINK into the
standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii)
workflow efficiency. As secondary objectives, the investigators will collect preliminary data
to examine the association between patient engagement with the RecoverLINK app and (i)
changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and
90-day time periods post-enrollment.
standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii)
workflow efficiency. As secondary objectives, the investigators will collect preliminary data
to examine the association between patient engagement with the RecoverLINK app and (i)
changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and
90-day time periods post-enrollment.
Inclusion Criteria:
- Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount
Sinai HF clinic
- English-speaking
- With either access to (i) an iOS smart device or (ii) wifi at-home
Exclusion Criteria:
Patients meeting any of the following criteria:
- A heart transplant
- A mechanical circulatory support (MCS) device
- An altered mental status
- Serious co-morbidities (as identified by Mount Sinai team)
- Cognitive impairments (as identified by Mount Sinai team)
- Inability to use technology (as identified by Mount Sinai team)
We found this trial at
1
site
Click here to add this to my saved trials
